Literature DB >> 16731845

Cognitive performance, psychological well-being, and brain magnetic resonance imaging in older patients with type 1 diabetes.

Augustina M A Brands1, Roy P C Kessels, Roel P L M Hoogma, Johanna M L Henselmans, Johanna W van der Beek Boter, L Jaap Kappelle, Edward H F de Haan, Geert Jan Biessels.   

Abstract

Modest cognitive impairment has been reported in young-adult patients with type 1 diabetes. In older patients with type 2 diabetes, cognitive impairments are more pronounced, which might be due to age but also to differential effects of type 1 diabetes and type 2 diabetes on the brain. This study therefore assessed cognitive performance and magnetic resonance imaging (MRI) of the brain in older type 1 diabetic patients. Forty type 1 diabetic patients (age >50 years) and 40 age-matched control subjects were included. Neuropsychological assessment included all major cognitive domains, and psychological well-being was assessed with questionnaires. Atrophy, white-matter abnormalities, and infarcts were rated on MRI scans. Type 1 diabetic patients performed slightly (effect sizes <0.4) worse on cognitive tasks, but only "speed of information processing" reached statistical significance. No significant between-group differences were found on any of the MRI parameters. Type 1 diabetic patients tended to report more cognitive and depressive problems than control subjects, but this did not correlate with the performance on cognitive tests. We conclude that cognition in older type 1 diabetic patients is only mildly disturbed. Chronic exposure to hyperglycemia is in itself, even at older age, apparently not sufficient to have considerable impact on the brain.

Entities:  

Mesh:

Year:  2006        PMID: 16731845     DOI: 10.2337/db05-1226

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  42 in total

1.  Thickness of the human cerebral cortex is associated with metrics of cerebrovascular health in a normative sample of community dwelling older adults.

Authors:  Elizabeth C Leritz; David H Salat; Victoria J Williams; David M Schnyer; James L Rudolph; Lewis Lipsitz; Bruce Fischl; Regina E McGlinchey; William P Milberg
Journal:  Neuroimage       Date:  2010-10-28       Impact factor: 6.556

2.  Frontal gray matter atrophy in middle aged adults with type 1 diabetes is independent of cardiovascular risk factors and diabetes complications.

Authors:  Timothy M Hughes; Christopher M Ryan; Howard J Aizenstein; Karen Nunley; Peter J Gianaros; Rachel Miller; Tina Costacou; Elsa S Strotmeyer; Trevor J Orchard; Caterina Rosano
Journal:  J Diabetes Complications       Date:  2013-08-30       Impact factor: 2.852

Review 3.  Diabetes and brain damage: more (or less) than meets the eye?

Authors:  Christopher M Ryan
Journal:  Diabetologia       Date:  2006-10       Impact factor: 10.122

4.  Diffusion tensor imaging identifies deficits in white matter microstructure in subjects with type 1 diabetes that correlate with reduced neurocognitive function.

Authors:  Christopher T Kodl; Daniel T Franc; Jyothi P Rao; Fiona S Anderson; William Thomas; Bryon A Mueller; Kelvin O Lim; Elizabeth R Seaquist
Journal:  Diabetes       Date:  2008-08-11       Impact factor: 9.461

5.  White Matter and Cognitive Changes in Veterans Diagnosed with Alcoholism and PTSD.

Authors:  Arkadiy L Maksimovskiy; Regina E McGlinchey; Catherine B Fortier; David H Salat; William P Milberg; Marlene Oscar-Berman
Journal:  J Alcohol Drug Depend       Date:  2014-01-01

6.  White matter hyperintensities in middle-aged adults with childhood-onset type 1 diabetes.

Authors:  Karen A Nunley; Christopher M Ryan; Trevor J Orchard; Howard J Aizenstein; J Richard Jennings; John Ryan; Janice C Zgibor; Robert M Boudreau; Tina Costacou; John D Maynard; Rachel G Miller; Caterina Rosano
Journal:  Neurology       Date:  2015-04-22       Impact factor: 9.910

Review 7.  Human cerebral neuropathology of Type 2 diabetes mellitus.

Authors:  Peter T Nelson; Charles D Smith; Erin A Abner; Frederick A Schmitt; Stephen W Scheff; Gregory J Davis; Jeffrey N Keller; Gregory A Jicha; Daron Davis; Wang Wang-Xia; Adria Hartman; Douglas G Katz; William R Markesbery
Journal:  Biochim Biophys Acta       Date:  2008-08-22

8.  Long-term effect of diabetes and its treatment on cognitive function.

Authors:  Alan M Jacobson; Gail Musen; Christopher M Ryan; Nancy Silvers; Patricia Cleary; Barbara Waberski; Amanda Burwood; Katie Weinger; Meg Bayless; William Dahms; Judith Harth
Journal:  N Engl J Med       Date:  2007-05-03       Impact factor: 91.245

9.  The effects of type 1 diabetes on cerebral white matter.

Authors:  K Weinger; A M Jacobson; G Musen; I K Lyoo; C M Ryan; D C Jimerson; P F Renshaw
Journal:  Diabetologia       Date:  2007-12-18       Impact factor: 10.122

10.  Pioglitazone ameliorates memory deficits in streptozotocin-induced diabetic mice by reducing brain β-amyloid through PPARγ activation.

Authors:  Li-ping Liu; Tian-hua Yan; Li-ying Jiang; Wei Hu; Meng Hu; Chao Wang; Qian Zhang; Yan Long; Jiang-qing Wang; Yong-qi Li; Mei Hu; Hao Hong
Journal:  Acta Pharmacol Sin       Date:  2013-03-25       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.